| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
|
Nat Med
|
2005
|
6.77
|
|
2
|
Persistence of Ebola Virus in Ocular Fluid during Convalescence.
|
N Engl J Med
|
2015
|
5.92
|
|
3
|
Clinical care of two patients with Ebola virus disease in the United States.
|
N Engl J Med
|
2014
|
5.74
|
|
4
|
Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola.
|
J Virol
|
2006
|
4.01
|
|
5
|
Effective post-exposure treatment of Ebola infection.
|
PLoS Pathog
|
2007
|
3.69
|
|
6
|
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
|
Lancet
|
2006
|
3.15
|
|
7
|
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.
|
J Virol
|
2004
|
2.99
|
|
8
|
Molecular Evidence of Sexual Transmission of Ebola Virus.
|
N Engl J Med
|
2015
|
2.71
|
|
9
|
Development of a new vaccine for the prevention of Lassa fever.
|
PLoS Med
|
2005
|
2.71
|
|
10
|
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
|
Vaccine
|
2008
|
2.33
|
|
11
|
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
|
J Virol
|
2006
|
1.85
|
|
12
|
Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses.
|
PLoS One
|
2009
|
1.83
|
|
13
|
Ectodomain shedding of the glycoprotein GP of Ebola virus.
|
EMBO J
|
2004
|
1.73
|
|
14
|
Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.
|
Clin Immunol
|
2011
|
1.73
|
|
15
|
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany.
|
J Infect Dis
|
2011
|
1.62
|
|
16
|
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function.
|
J Virol
|
2005
|
1.61
|
|
17
|
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
|
J Virol
|
2006
|
1.61
|
|
18
|
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola.
|
PLoS Negl Trop Dis
|
2011
|
1.53
|
|
19
|
Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.
|
J Virol
|
2010
|
1.49
|
|
20
|
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States.
|
Ann Intern Med
|
2015
|
1.47
|
|
21
|
Reemerging Sudan Ebola virus disease in Uganda, 2011.
|
Emerg Infect Dis
|
2012
|
1.47
|
|
22
|
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages.
|
J Virol
|
2005
|
1.47
|
|
23
|
Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry.
|
J Virol
|
2011
|
1.23
|
|
24
|
Ebola virus ecology: a continuing mystery.
|
Trends Microbiol
|
2004
|
1.19
|
|
25
|
Clinical inquiries regarding Ebola virus disease received by CDC--United States, July 9-November 15, 2014.
|
MMWR Morb Mortal Wkly Rep
|
2014
|
1.10
|
|
26
|
Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers.
|
Virology
|
2007
|
1.02
|
|
27
|
Molecular characterization of an isolate from the 1989/90 epizootic of Ebola virus Reston among macaques imported into the United States.
|
Virus Res
|
2002
|
1.01
|
|
28
|
Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012.
|
Emerg Infect Dis
|
2014
|
0.96
|
|
29
|
Lymphocytic choriomeningitis virus in employees and mice at multipremises feeder-rodent operation, United States, 2012.
|
Emerg Infect Dis
|
2014
|
0.92
|
|
30
|
Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.
|
PLoS Negl Trop Dis
|
2009
|
0.91
|
|
31
|
Andes hantavirus variant in rodents, southern Amazon Basin, Peru.
|
Emerg Infect Dis
|
2014
|
0.91
|
|
32
|
Solid organ transplant-associated lymphocytic choriomeningitis, United States, 2011.
|
Emerg Infect Dis
|
2012
|
0.90
|
|
33
|
An antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.
|
J Virol
|
2010
|
0.89
|
|
34
|
Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation - Iowa, 2013.
|
MMWR Morb Mortal Wkly Rep
|
2014
|
0.84
|
|
35
|
Novel paramyxovirus associated with severe acute febrile disease, South Sudan and Uganda, 2012.
|
Emerg Infect Dis
|
2014
|
0.84
|
|
36
|
Trace-forward investigation of mice in response to lymphocytic choriomeningitis virus outbreak.
|
Emerg Infect Dis
|
2014
|
0.83
|
|
37
|
Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.
|
J Virol
|
2009
|
0.82
|
|
38
|
Breakdown of paraendothelial barrier function during Marburg virus infection is associated with early tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1.
|
J Infect Dis
|
2007
|
0.79
|
|
39
|
Nipah Virus Transmission from Bats to Humans Associated with Drinking Traditional Liquor Made from Date Palm Sap, Bangladesh, 2011-2014.
|
Emerg Infect Dis
|
2016
|
0.79
|
|
40
|
Crimean-Congo hemorrhagic fever virus, Greece.
|
Emerg Infect Dis
|
2014
|
0.78
|
|
41
|
In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.
|
J Infect Dis
|
2007
|
0.78
|
|
42
|
Laboratory Response to Ebola - West Africa and United States.
|
MMWR Suppl
|
2016
|
0.77
|
|
43
|
Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation-Iowa, 2013.
|
Am J Transplant
|
2014
|
0.77
|
|
44
|
Isolated Case of Marburg Virus Disease, Kampala, Uganda, 2014.
|
Emerg Infect Dis
|
2017
|
0.76
|
|
45
|
Exposure-based screening for Nipah virus encephalitis, Bangladesh.
|
Emerg Infect Dis
|
2015
|
0.75
|
|
46
|
Pregnancy, Labor, and Delivery after Ebola Virus Disease and Implications for Infection Control in Obstetric Services, United States.
|
Emerg Infect Dis
|
2016
|
0.75
|
|
47
|
Implementation of a National Semen Testing and Counseling Program for Male Ebola Survivors - Liberia, 2015-2016.
|
MMWR Morb Mortal Wkly Rep
|
2016
|
0.75
|